A combination of omega-3 and low-dose acetylsalicylic acid (ASA) achieved clinical results comparable to antibiotics in treating severe periodontitis, according to a study published in the May issue of the Journal of Periodontology. Researchers affiliated with Albert Einstein Israelite Hospital, Guarulhos University, the University of Taubaté, and the Ribeirão Preto School of Dentistry at USP in Brazil, alongside Harvard University in the United States, tracked 109 patients with advanced periodontitis over one year to evaluate non-antibiotic alternatives for the chronic inflammatory disease.
Clinical Trial Design and Patient Outcomes in Advanced Periodontitis
Advanced periodontitis is a chronic inflammatory disease caused by bacteria accumulating beneath the gums, which can result in tooth mobility, bone loss, and tooth loss if left untreated. “Patients with severe disease have very deep pockets, which act as reservoirs for bacteria associated with the disease. It’s a very challenging condition to treat,” according to dental surgeon Nídia Cristina Castro dos Santos, the first author of the study and a professor and researcher at Einstein. For the trial, supported by FAPESP under projects 20/05874-2 and 20/05875-9, 109 participants underwent subgingival instrumentation, or scaling, as standard treatment before being assigned to one of four complementary therapy groups.
The control group received identical placebo capsules for antibiotics, omega-3, and ASA. A second group received the antibiotics metronidazole and amoxicillin three times daily for 14 days. The third group took three grams of omega-3 daily alongside a daily dose of aspirin for six months. A fourth group combined both the two-week antibiotic protocol and the six-month omega-3 and ASA regimen simultaneously. Following reevaluations at three, six, and twelve months, about 58% of patients treated with antibiotics met the clinical goal of retaining no more than four deep periodontal pockets. Among those treated with omega-3 and ASA, the success rate was virtually identical at 57.7%. In contrast, the scaling and placebo group recorded a success rate of 23.1%, while combining antibiotics and supplementation provided no additional clinical benefits.
Did you know? Researchers noted that the benefits of the omega-3 and aspirin supplementation persisted for six months after the treatment protocol ended, suggesting that modulating the body’s inflammatory response produces lasting therapeutic effects.
Antibiotic Resistance Concerns Drive Alternative Periodontal Therapies
The search for non-antibiotic treatments stems from growing global concerns regarding bacterial resistance. “The use of antibiotics isn’t considered the gold standard of treatment. Although metronidazole and amoxicillin yield good results in the most severe cases, their use should be evaluated on a case-by-case basis due to risks related to bacterial resistance and possible adverse effects,” Castro dos Santos states. Previous research supported by FAPESP and published in Scientific Reports had already demonstrated that omega-3 supplementation reduced inflammation and bone loss in rats with periodontal disease, particularly when paired with physical exercise.
Unlike traditional anti-inflammatory medications that block specific inflammatory pathways, omega-3 contributes to the production of molecules that naturally resolve inflammation and repair tissue. Low-dose ASA is added to the protocol because it enhances the formation of these mediators. “We imagined that the combination of omega-3 and low-dose aspirin would be slightly lower than those for the antibiotic group. The result was surprising because the two therapies performed very similarly, paving the way for it to become a treatment option for these patients,” Castro dos Santos explains.
Expert Perspective on Inflammatory Modulation and Future Dental Care
Dental surgeon Magda Feres, lead author of the study, full professor at the Harvard School of Dental Medicine, and professor in the Graduate Program in Dentistry at UNG, notes that modulating the inflammatory response offers a viable alternative for selected populations. “The combination of omega-3 and low-dose aspirin achieved clinical benefits comparable to those of the metronidazole and amoxicillin protocol, opening up a real alternative for those who can’t take antibiotics, especially patients with allergies or intolerance to these medications,” she says. Feres emphasizes that demonstrating the efficacy of treating severe periodontitis through the body’s own immune response helps preserve antibiotics for cases where they are genuinely indispensable.
Despite these promising findings, the authors caution that the data does not translate to an immediate shift in clinical practice, as the study evaluated patients without significant systemic or oral diseases. Ongoing microbiological analyses are currently examining how these therapies alter the composition of bacteria within periodontal pockets, with preliminary data indicating a decrease in disease-associated species and an increase in health-related microorganisms. Additional research across diverse populations is required before routine clinical replacement can occur.
Frequently Asked Questions
What is advanced periodontitis?
Advanced periodontitis is a chronic inflammatory condition caused by bacteria building up beneath the gums, which damages supporting tissues and can lead to tooth mobility, bone loss, and tooth loss.
How did the omega-3 and aspirin treatment compare to antibiotics?
According to the study published in the Journal of Periodontology, 58% of patients treated with antibiotics met the clinical goal of having four or fewer remaining deep periodontal pockets, compared to 57.7% of patients treated with a combination of omega-3 and low-dose acetylsalicylic acid.
Can omega-3 and aspirin immediately replace antibiotics for gum disease?
No. Researchers emphasize that while the findings offer a scientifically plausible alternative for patients who cannot tolerate antibiotics, further research and microbiological testing are necessary before updating standard clinical practice.
What are your thoughts on utilizing nutritional supplements to combat antibiotic resistance in dental care? Share your perspective in the comments below, or explore our archive for more clinical research updates.
Keep reading